Does LOMITAPIDE Cause Product dose omission issue? 100 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Product dose omission issue have been filed in association with LOMITAPIDE (Juxtapid). This represents 2.7% of all adverse event reports for LOMITAPIDE.
100
Reports of Product dose omission issue with LOMITAPIDE
2.7%
of all LOMITAPIDE reports
0
Deaths
19
Hospitalizations
How Dangerous Is Product dose omission issue From LOMITAPIDE?
Of the 100 reports, 19 (19.0%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMITAPIDE. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does LOMITAPIDE Cause?
Diarrhoea (1,071)
Therapy cessation (828)
Weight decreased (828)
Nausea (567)
Abdominal pain upper (280)
Flatulence (244)
Abdominal discomfort (228)
Vomiting (211)
Off label use (206)
Fatigue (200)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which LOMITAPIDE Alternatives Have Lower Product dose omission issue Risk?
LOMITAPIDE vs LOMUSTINE
LOMITAPIDE vs LONAPEGSOMATROPIN-TCGD
LOMITAPIDE vs LONCASTUXIMAB TESIRINE-LPYL
LOMITAPIDE vs LOPERAMIDE
LOMITAPIDE vs LOPINAVIR